Article citationsMore>>

Schnabel, R., Lubos, E., Rupprecht, H.J., Espinola-Klein, C., Bickel, C., Lackner, K.J., Cambien, F., Tiret, L., Munzel, T. and Blankenberg, S. (2006) B-type natriu- retic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the Athero Gene study. Journal of the American College of Cardiology, 47, 552-8.

has been cited by the following article:

• TITLE: Cardio-Toxicity during chemotherapy: feasibility of new diagnostic approaches

  AUTHORS: Fable Zustovich, Mario Trivellato, Renato Ceravolo, Davide Pastorelli, Rosanna Canton, Lorena Buratin, Monica Mion, Martina Zaninotto, Martina Mattiazzi, Mario Plebani, Giuseppe Cartei

  KEYWORDS: Cardio-Toxicity Diagnostic

  JOURNAL NAME: Health, Vol.2 No.4, May 4, 2010

  ABSTRACT: Chemotherapy induced cardio-toxicity is a well known side effect of anticancer treatments, moreover the 70% of all tumors involve patients over 65 years-old, frequently with cardiac co- morbidity. We evaluated the feasibility of the application during chemotherapy administration of some of the most recent diagnostic techniques as 12-diagnostic leads telemetry, 7 days EKG monitoring device (R-Test Evolution 3R), blood level dosage of Brain Natriuretic Peptide (BNP) and Ischemia Modified Albumin (IMA). Some sub-clinical changes in the investigated parameters were found in patients undergoing chemotherapy, mostly containing fluorouracil, as shown in the following paper. Far from suggesting a widespread use of these methods during chemotherapy administration, we think that some more tools are needed to prevent cardiac toxicity in high-risk patients and some of what we studied may deserve further valuation in chemotherapy clinical trials.